The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Regulatory News (COST)

Share Price Information for Costain (COST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 83.20
Bid: 82.40
Ask: 83.40
Change: -0.80 (-0.95%)
Spread: 1.00 (1.214%)
Open: 82.60
High: 84.20
Low: 82.60
Prev. Close: 84.00
COST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Year End Trading Update

3 Jan 2019 07:00

RNS Number : 0078M
Costain Group PLC
03 January 2019
 

3 January 2019

 

Costain Group PLC

("Costain" or "the Group" or "the Company")

 

 

Year End Trading Update

 

Costain, the smart infrastructure solutions company, today issues a trading update ahead of announcing results for the year ended 31 December 2018 on 6 March 2019.

 

The Group has continued to perform well in the second half and expects to deliver full-year results in line with the Board's expectations.

 

This year has seen the Group make further progress on its strategy of transforming Costain into the UK's leading smart infrastructure solutions company. Costain is differentiating itself through its long-term strategic relationships and integrated technology-enabled services necessitated by the increasingly complex and fast-changing nature of its clients' requirements. The Group continues to be involved in a number of major regulatory-driven procurement processes.

 

The Group has finished the year with an order book at a record level of £4.2 billion (31 December 2017: £3.9 billion), reflecting Costain's market position with its target clients who are consolidating their supply chains to deliver increasingly large, multi-billion pound investment programmes underpinned by regulatory commitments. In addition, the Group's preferred bidder position stands at c £600 million (31 December 2017: £400 million).

The Group finished the year with a strong net cash position of over £110 million, in line with expectations, (31 December 2017: £177.7million) with the reduction from last year's exceptionally high level due to the timing of receipts in that period. Throughout the year the Group had a positive net cash position with an average month-end net cash balance of c £77 million (2017: £96.7 million).

Andrew Wyllie CBE, chief executive, said:

"This has been another year of progress for Costain. The benefits of our integrated offering, long-term strategic relationships with our clients and strong balance sheet position us well for the future and the significant opportunity we see across our rapidly-changing end markets."

 

 

Enquiries:

 

Costain

Tel: 01628 842 444

Andrew Wyllie CBE, Chief Executive

Tony Bickerstaff, Chief Financial Officer

Carolyn Rich, Investor Relations Director

Sara Lipscombe, Group Communications Director

Instinctif Partners

Tel: 020 7457 2020

Mark Garraway

James Gray

 

 

Notes to Editors

 

Costain helps to improve people's lives by deploying technology-based engineering solutions to meet urgent national needs across the UK's energy, water and transportation infrastructures. We have been shaping the world in which we live for the past 150 years.

 

The Group's 'Engineering Tomorrow' strategy involves focusing on blue chip clients in chosen sectors whose major spending plans are underpinned by strategic national needs, regulatory commitments or essential maintenance requirements.

 

Costain's 4,000 people are committed to high performance and safe delivery. They are delivering a broad range of innovative services including consultancy, technology, asset optimisation and complex delivery services across a range of high profile contracts in the UK incorporating the whole life cycle of our clients' assets.

 

For more information visit www.costain.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTBTMFTMBJMBAL
Date   Source Headline
11th Nov 20159:56 amRNSBlocklisting Interim Review
30th Oct 201510:01 amRNSTotal Voting Rights
29th Oct 20159:42 amRNSHolding(s) in Company
20th Oct 20151:03 pmRNS2015 Interim Dividend - Scrip Alternative
28th Sep 201511:09 amRNSDirector/PDMR Shareholding
25th Sep 201511:34 amRNSHolding(s) in Company
24th Sep 201510:35 amRNSScrip Dividend Reference Price
15th Sep 20152:45 pmRNSTransfer of Shares
14th Sep 201511:22 amRNSHolding(s) in Company
11th Sep 201510:18 amRNSBoard Change
11th Sep 201510:12 amRNSHolding(s) in Company
24th Aug 20157:06 amRNSRe Contract
20th Aug 20157:00 amRNSHalf Yearly Report
17th Aug 20157:00 amRNSAcquisition
28th Jul 20159:33 amRNSNED Appointment
22nd Jul 20157:00 amRNSRe Contract
22nd Jul 20157:00 amRNSCompletion of Reorganisation of JV in Spain
1st Jul 20159:58 amRNSBlocklisting Interim Review
1st Jul 20157:00 amRNSChanges to JV in Spain
25th Jun 20157:00 amRNSTrading Update
5th Jun 20157:00 amRNSBusiness Briefing
3rd Jun 20157:00 amRNSRe Contract
29th May 20159:17 amRNSTotal Voting Rights and Capital
19th May 201510:24 amRNSDividend - Scrip Alternative
12th May 201510:34 amRNSDirector/PDMR Shareholding
8th May 20154:23 pmRNSLTIP - Blocklisting Application - Correction
7th May 201511:11 amRNSLong Term Incentive Plan - Listing Application
6th May 201511:49 amRNSResult of AGM
6th May 20157:01 amRNSAnnual General Meeting and Financial Calendar
30th Apr 20158:59 amRNSTotal Voting Rights and Capital
23rd Apr 20152:33 pmRNSScrip Dividend Reference Price
8th Apr 201512:25 pmRNSDirector/PDMR Shareholding
31st Mar 201511:16 amRNSTotal Voting Rights
23rd Mar 20157:00 amRNSRe Contract
20th Mar 20157:00 amRNSNotice of AGM and Annual Report and Accounts
17th Mar 201510:18 amRNSHolding(s) in Company
10th Mar 201510:11 amRNSDirector/PDMR Shareholding
3rd Mar 20152:39 pmRNSDividend Declaration
3rd Mar 20157:00 amRNSFinal Results
27th Feb 20159:00 amRNSTotal Voting Rights
30th Jan 20159:00 amRNSTotal Voting Rights
7th Jan 20157:00 amRNSTrading Update
2nd Jan 20157:00 amRNSBlocklisting Interim Review
2nd Jan 20157:00 amRNSTotal Voting Rights
18th Dec 201412:56 pmRNSHolding(s) in Company
10th Dec 20147:00 amRNSHolding(s) in Company
1st Dec 20149:00 amRNSTotal Voting Rights
17th Nov 20147:00 amRNSRe Contract
14th Nov 20149:00 amRNSDirector/PDMR Shareholding
10th Nov 20147:00 amRNSRe Contract

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.